Cart
sales@molnova.com
Taurochenodeoxycholic Acid
CAS No. 516-35-8
Taurochenodeoxycholic Acid( 12-Deoxycholyltaurine )
Catalog No. M18702 CAS No. 516-35-8
Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 32 | In Stock |
|
| 25MG | 37 | In Stock |
|
| 50MG | 55 | In Stock |
|
| 100MG | 83 | In Stock |
|
| 200MG | 119 | In Stock |
|
| 500MG | 204 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTaurochenodeoxycholic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionTaurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.
-
DescriptionTaurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.
-
In Vitro——
-
In Vivo——
-
Synonyms12-Deoxycholyltaurine
-
PathwayOthers
-
TargetOther Targets
-
RecptorCaspase| TNF-α
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number516-35-8
-
Formula Weight499.7
-
Molecular FormulaC26H45NO6S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 25 mg/mL; 50.03 mM
-
SMILESO=S(=O)(O)CCNC(=O)CC[C@@H](C)[C@H]4CC[C@@H]1[C@]4(C)CC[C@@H]2[C@@]3(C)CC[C@@H](O)C[C@H]3C[C@@H](O)[C@@H]12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang X, et al. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway. Eur J Pharmacol. 2016 Sep 5;786:109-15.
molnova catalog
related products
-
Rutarin
Rutarin is a Coumarin derivative, that can be isolated from the aerial parts of the plant Atalantta racemosa.
-
LysoPC(14:0/0:0)
LysoPC(14:0/0:0) is a lysophospholipid (LyP) and mono-glycerophospholipid.
-
Compound K
HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.
